Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...

No technical experience? No worries. These website builders will help you create your blog, portfolio or online shop without using a single line of code. Website builders are visual design tools ...

The statewide moratorium on natural gas utility disconnections ends March 15, including customers who qualified for the EAP ...

Minnesota Housing is hiring! We’re a mission-focused financial institution looking for a Community Reviewer Program Manager who will drive the development, implementation, and growth of the Community ...

Under Indiana law, utilities cannot disconnect customers in the winter under certain conditions. The moratorium runs from Dec ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Q4 2024 Earnings Call Transcript March 11, 2025 Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024Entered into asset purchase agreement ...

Sascha Byrne plays a vital role at the ACA, wearing many hats. One of the most important is her role as Wellbeing Program ...

Industry Leading Health Coverage Short and Long-term Disability Team Member and Dependent Life Insurance Group Voluntary Benefits Wellness programs through EAP and Headspace Matching 401(k ...

Leveraging the power of the best AI website builders can help you build a better website faster than ever before. Wix tops the list thanks to its offering of powerful AI tools and a fully text ...